Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Hepatitis

  Free Subscription


Articles published in Arch Virol

Retrieve available abstracts of 59 articles:
HTML format
Text format



Single Articles


    March 2017
  1. HAMZA H, Abd-Elshafy DN, Fayed SA, Bahgat MM, et al
    Detection and characterization of hepatitis A virus circulating in Egypt.
    Arch Virol. 2017 Mar 16. doi: 10.1007/s00705-017-3294.
    PubMed     Text format     Abstract available


  2. CASTELAIN S, Descamps V, Brochot E, Helle F, et al
    High association of T1858-G1896 precore mutations with impaired base pairing and high hepatitis B virus DNA levels in HBeAg-negative chronically infected patients.
    Arch Virol. 2017 Mar 13. doi: 10.1007/s00705-017-3312.
    PubMed     Text format     Abstract available


    February 2017
  3. BENSALEM A, Selmani K, Narjes H, Bencherifa N, et al
    Widespread geographical disparities in chronic hepatitis B virus infection in Algeria.
    Arch Virol. 2017 Feb 24. doi: 10.1007/s00705-017-3284.
    PubMed     Text format     Abstract available


  4. MUGOSA B, Cella E, Lai A, Lo Presti A, et al
    Hepatitis C virus genotype 3A in a population of injecting drug users in Montenegro: Bayesian and evolutionary analysis.
    Arch Virol. 2017 Feb 13. doi: 10.1007/s00705-017-3224.
    PubMed     Text format     Abstract available


  5. SPITZ N, Moreira AS, Mello FC, Franz HC, et al
    Complete genome sequence of a hepatitis B virus isolate of genotype D2, subtype adrq+, from Brazil.
    Arch Virol. 2017 Feb 8. doi: 10.1007/s00705-017-3269.
    PubMed     Text format     Abstract available


  6. NICZYPORUK JS
    Molecular characterisation of fowl adenovirus type 7 isolated from poultry associated with inclusion body hepatitis in Poland.
    Arch Virol. 2017 Feb 3. doi: 10.1007/s00705-017-3240.
    PubMed     Text format     Abstract available


    November 2016
  7. PISANO MB, Balderramo D, Wassaf MM, Lotto M, et al
    Hepatitis E virus infection in patients on dialysis and in solid organ transplant recipients in Argentina: exploring associated risk factors.
    Arch Virol. 2016.
    PubMed     Text format     Abstract available


  8. PURDY MA, Sue A
    The effect of phylogenetic signal reduction on genotyping of hepatitis E viruses of the species Orthohepevirus A.
    Arch Virol. 2016.
    PubMed     Text format     Abstract available


    October 2016
  9. SANTANA LC, Mantovani NP, Ferreira MC, Arnold R, et al
    Identification of a new hepatitis B virus recombinant D2/D3 in the city of Sao Paulo, Brazil.
    Arch Virol. 2016.
    PubMed     Text format     Abstract available


  10. ZHANG Z, Zhang Y, Xu N, Huang C, et al
    High risk of occult hepatitis B virus infection in leukemia patients from China.
    Arch Virol. 2016.
    PubMed     Text format     Abstract available


  11. ANDRADE AP, Pacheco SD, Silva FQ, Pinheiro LM, et al
    Characterization of hepatitis B virus infection in illicit drug users in the Marajo Archipelago, northern Brazil.
    Arch Virol. 2016.
    PubMed     Text format     Abstract available


  12. SEDIGHIMEHR P, Irani S, Sakhaee F, Vaziri F, et al
    IL28B rs12980275 and HLA rs4273729 genotypes as a powerful predictor factor for rapid, early, and sustained virologic response in patients with chronic hepatitis C.
    Arch Virol. 2016.
    PubMed     Text format     Abstract available


  13. NOBLE CF, Malta F, Lisboa-Neto G, Gomes-Gouvea MS, et al
    Natural occurrence of NS5B inhibitor resistance-associated variants in Brazilian patients infected with HCV or HCV and HIV.
    Arch Virol. 2016.
    PubMed     Text format     Abstract available


    September 2016
  14. HELALY GF, Elsheredy AG, El Basset Mousa AA, Ahmed HK, et al
    Seronegative and occult hepatitis C virus infections in patients with hematological disorders.
    Arch Virol. 2016.
    PubMed     Text format     Abstract available


  15. ZAGHLOUL H, El Morsi AA, Soweha HE, Elsayed A, et al
    A simple real-time polymerase chain reaction assay using SYBR Green for hepatitis C virus genotyping.
    Arch Virol. 2016.
    PubMed     Text format     Abstract available


  16. AGHASADEGHI MR, Velayati AA, Mamishi S, Nabavi M, et al
    Low prevalence of hepatitis B vaccine escape mutants among individuals born after the initiation of a nationwide vaccination program in Iran.
    Arch Virol. 2016.
    PubMed     Text format     Abstract available


  17. TAKAHASHI M, Kobayashi T, Tanggis, Jirintai S, et al
    Production of monoclonal antibodies against the ORF3 protein of rat hepatitis E virus (HEV) and demonstration of the incorporation of the ORF3 protein into enveloped rat HEV particles.
    Arch Virol. 2016.
    PubMed     Text format     Abstract available


    August 2016
  18. MEHTA M, Hetta HF, Abdel-Hameed EA, Rouster SD, et al
    Association between IL28B rs12979860 single nucleotide polymorphism and the frequency of colonic Treg in chronically HCV-infected patients.
    Arch Virol. 2016.
    PubMed     Text format     Abstract available


    July 2016
  19. JONES LR, Sede M, Manrique JM, Quarleri J, et al
    Hepatitis B virus resistance substitutions: long-term analysis by next-generation sequencing.
    Arch Virol. 2016.
    PubMed     Text format     Abstract available


  20. GOLSAZ-SHIRAZI F, Mohammadi H, Amiri MM, Khoshnoodi J, et al
    Localization of immunodominant epitopes within the "a" determinant of hepatitis B surface antigen using monoclonal antibodies.
    Arch Virol. 2016.
    PubMed     Text format     Abstract available


  21. DE CONTO F, Medici MC, Ferraglia F, Pinardi F, et al
    Temporal dynamics of hepatitis C genotypes in a five-year hospital-based surveillance in Northern Italy.
    Arch Virol. 2016.
    PubMed     Text format     Abstract available


  22. DI PROFIO F, Melegari I, Sarchese V, Robetto S, et al
    Detection and genetic characterization of hepatitis E virus (HEV) genotype 3 subtype c in wild boars in Italy.
    Arch Virol. 2016.
    PubMed     Text format     Abstract available


  23. PISANO MB, Blanco S, Carrizo H, Re VE, et al
    Hepatitis B virus infection in blood donors in Argentina: prevalence of infection, genotype distribution and frequency of occult HBV infection.
    Arch Virol. 2016.
    PubMed     Text format     Abstract available


    June 2016
  24. ABDELRAHEEM WM, Hassuna NA, Abuloyoun SM, Abdel Ghany HM, et al
    Interleukin-10.rs1800896 and Interleukin-18.rs1946518 gene polymorphisms could not predict the outcome of hepatitis C virus infection in Egyptian patients treated with pegylated interferon plus ribavirin.
    Arch Virol. 2016.
    PubMed     Text format     Abstract available


  25. EL-BENDARY M, Hawas S, El-Hammady D, Al-Hadidy AM, et al
    Profile of expression of certain markers of apoptosis in chronic hepatitis C and hepatitis B patients in an Egyptian population.
    Arch Virol. 2016.
    PubMed     Text format     Abstract available


  26. CHOI JW, Jung JY, Lee JI, Lee KK, et al
    Molecular characteristics of a novel strain of canine minute virus associated with hepatitis in a dog.
    Arch Virol. 2016.
    PubMed     Text format     Abstract available


    May 2016
  27. GASPARETO KV, Ribeiro RM, de Mello Malta F, Gomes-Gouvea MS, et al
    HCV inter-subtype 1a/1b recombinant detected by complete-genome next-generation sequencing.
    Arch Virol. 2016.
    PubMed     Text format     Abstract available


  28. KONG L, Li S, Yu X, Fang X, et al
    Hepatitis C virus and its protein NS4B activate the cancer-related STAT3 pathway via the endoplasmic reticulum overload response.
    Arch Virol. 2016.
    PubMed     Text format     Abstract available


    April 2016
  29. BASTANI MN, Bokharaei-Salim F, Keyvani H, Esghaei M, et al
    Prevalence of occult hepatitis C virus infection in Iranian patients with beta thalassemia major.
    Arch Virol. 2016.
    PubMed     Text format     Abstract available


  30. GONG T, Zhao X, Luo Y, Hong Y, et al
    Distribution of hepatitis C virus genotypes in volunteer blood donors from Chengdu, China.
    Arch Virol. 2016.
    PubMed     Text format     Abstract available


    March 2016
  31. DE SEIXAS SANTOS NASTRI AC, de Mello Malta F, Diniz MA, Yoshino A, et al
    Association of IFNL3 and IFNL4 polymorphisms with hepatitis C virus infection in a population from southeastern Brazil.
    Arch Virol. 2016.
    PubMed     Text format     Abstract available


    February 2016
  32. ZHANG Y, Cheng J, Liu C
    The unique role of the hepatitis virus B X protein on HEK 293 cell morphology and cellular change.
    Arch Virol. 2016.
    PubMed     Text format     Abstract available


  33. DI BARTOLO I, De Sabato L, Marata A, Martinelli N, et al
    Serological survey of hepatitis E virus infection in farmed and pet rabbits in Italy.
    Arch Virol. 2016.
    PubMed     Text format     Abstract available


  34. JOVANOVIC-CUPIC S, Glisic S, Stanojevic M, Nozic D, et al
    The influence of host factors and sequence variability of the p7 region on the response to pegylated interferon/ribavirin therapy for chronic hepatitis C genotype 1b in patients from Serbia.
    Arch Virol. 2016.
    PubMed     Text format     Abstract available


  35. GALANI BR, Sahuc ME, Sass G, Njayou FN, et al
    Khaya grandifoliola C.DC: a potential source of active ingredients against hepatitis C virus in vitro.
    Arch Virol. 2016.
    PubMed     Text format     Abstract available


    December 2015
  36. SEGGEWISS N, Kruse HV, Weilandt R, Domsgen E, et al
    Cellular localization and effects of ectopically expressed hepatitis A virus proteins 2B, 2C, 3A and their intermediates 2BC, 3AB and 3ABC.
    Arch Virol. 2015.
    PubMed     Text format     Abstract available


  37. IKEZAKI H, Furusyo N, Hiramine S, Ura K, et al
    Association of IL28B rs8099917 genotype and female sex with spontaneous clearance of hepatitis C virus infection: a Japanese cross-sectional study.
    Arch Virol. 2015.
    PubMed     Text format     Abstract available


  38. LI WY, Ren JH, Tao NN, Ran LK, et al
    The SIRT1 inhibitor, nicotinamide, inhibits hepatitis B virus replication in vitro and in vivo.
    Arch Virol. 2015.
    PubMed     Text format     Abstract available


    November 2015
  39. HERNANDEZ S, Jimenez G, Alarcon V, Prieto C, et al
    Replication of a chronic hepatitis B virus genotype F1b construct.
    Arch Virol. 2015.
    PubMed     Text format     Abstract available


  40. LIN SL, Cong RC, Zhang RH, Chen JH, et al
    Circulation and in vivo distribution of duck hepatitis A virus types 1 and 3 in infected ducklings.
    Arch Virol. 2015.
    PubMed     Text format     Abstract available


    October 2015
  41. MWANGI J, Nganga Z, Mpoke S, Lihana R, et al
    Hepatitis C virus genotypes in Kenya.
    Arch Virol. 2015.
    PubMed     Text format     Abstract available


  42. SEGGEWISS N, Paulmann D, Dotzauer A
    Lysosomes serve as a platform for hepatitis A virus particle maturation and nonlytic release.
    Arch Virol. 2015.
    PubMed     Text format     Abstract available


  43. AKIL A, Wedeh G, Zahid Mustafa M, Gassama-Diagne A, et al
    SUMO1 depletion prevents lipid droplet accumulation and HCV replication.
    Arch Virol. 2015.
    PubMed     Text format     Abstract available


  44. HADIJI-ABBES N, Mihoubi W, Martin M, Karakasyan-Dia C, et al
    Characterization of C69R variant HBsAg: effect on binding to anti-HBs and the structure of virus-like particles.
    Arch Virol. 2015;160:2427-33.
    PubMed     Text format     Abstract available


    September 2015
  45. ISLAM MM, Toohey B, Purcell DF, Kannourakis G, et al
    Suppression subtractive hybridization method for the identification of a new strain of murine hepatitis virus from xenografted SCID mice.
    Arch Virol. 2015.
    PubMed     Text format     Abstract available


    August 2015
  46. XIA J, Zeng H, Liu L, Zhang Y, et al
    Swine and rabbits are the main reservoirs of hepatitis E virus in China: detection of HEV RNA in feces of farmed and wild animals.
    Arch Virol. 2015.
    PubMed     Text format     Abstract available


  47. ABDELWAHAB SF, Zakaria Z, Allam WR, Hamdy S, et al
    Interleukin 28B.rs12979860 genotype does not affect hepatitis C viral load in Egyptians with genotype 4 chronic infection.
    Arch Virol. 2015.
    PubMed     Text format     Abstract available


  48. RUGGIERO T, Proietti A, Boglione L, Milia MG, et al
    Predominance of hepatitis C virus Q80K among NS3 baseline-resistance-associated amino acid variants in direct-antiviral-agent-naive patients with chronic hepatitis: single-centre experience.
    Arch Virol. 2015.
    PubMed     Text format     Abstract available


  49. GUZMAN-HERRADOR BR, Panning M, Stene-Johansen K, Borgen K, et al
    Importance of molecular typing in confirmation of the source of a national hepatitis A virus outbreak in Norway and the detection of a related cluster in Germany.
    Arch Virol. 2015.
    PubMed     Text format     Abstract available


    July 2015
  50. YANG Z, Lei Y, Chen C, Ren H, et al
    Roles of the programmed cell death 1, T cell immunoglobulin mucin-3, and cluster of differentiation 288 pathways in the low reactivity of invariant natural killer T cells after chronic hepatitis B virus infection.
    Arch Virol. 2015.
    PubMed     Text format     Abstract available


  51. GUAN J, Deng Y, Chen H, Yin X, et al
    Priming with two DNA vaccines expressing hepatitis C virus NS3 protein targeting dendritic cells elicits superior heterologous protective potential in mice.
    Arch Virol. 2015.
    PubMed     Text format     Abstract available


  52. CHENG XD, Xu HF, Wei XM, Zhou HZ, et al
    Variation analysis of E1 and E2 in HCV subtypes.
    Arch Virol. 2015.
    PubMed     Text format     Abstract available


    June 2015
  53. LOPEZ L, Flichman D, Mojsiejczuk L, Gonzalez MV, et al
    Genetic variability of hepatitis B virus in Uruguay: D/F, A/F genotype recombinants.
    Arch Virol. 2015.
    PubMed     Text format     Abstract available


  54. SADIK NA, Shaker OG, Ghanem HZ, Hassan HA, et al
    Single-nucleotide polymorphism of Toll-like receptor 4 and interleukin-10 in response to interferon-based therapy in Egyptian chronic hepatitis C patients.
    Arch Virol. 2015.
    PubMed     Text format     Abstract available


  55. ZHU B, Wei XX, Wang TB, Zhou YC, et al
    Increased miR-16 expression induced by hepatitis C virus infection promotes liver fibrosis through downregulation of hepatocyte growth factor and Smad7.
    Arch Virol. 2015.
    PubMed     Text format     Abstract available


  56. BOGLIONE L, Cusato J, Allegra S, Cariti G, et al
    Role of IL28B genotyping in patients with hepatitis C virus-associated mixed cryoglobulinemia and response to PEG-IFN and ribavirin treatment.
    Arch Virol. 2015.
    PubMed     Text format     Abstract available


  57. SHEHAT MG, Bahey-El-Din M, Kassem MA, Farghaly FA, et al
    Recombinant expression of the alternate reading frame protein (ARFP) of hepatitis C virus genotype 4a (HCV-4a) and detection of ARFP and anti-ARFP antibodies in HCV-infected patients.
    Arch Virol. 2015.
    PubMed     Text format     Abstract available


    May 2015
  58. DE ALMEIDA SILVA JL, De Deus DM, Moreira RC, de Morais CN, et al
    The relationship between hepatitis B virus (HBV) load and levels of transforming growth factor beta 1 (TGF-beta1) and soluble Fas (sFas) in human immunodeficiency virus patients with occult HBV infection.
    Arch Virol. 2015.
    PubMed     Text format     Abstract available


  59. ABDELWAHAB SF, Zakaria Z, Sobhy M, Hamdy S, et al
    Differential distribution of IL28B.rs12979860 single-nucleotide polymorphism among Egyptian healthcare workers with and without a hepatitis C virus-specific cellular immune response.
    Arch Virol. 2015.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Hepatitis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: